Drug: treprostinil 0.6 MG/ML soln (tyvaso 0.6 MG/ML) refill kit
Ended Awarded Last action
- Contract number
- VA26017J1606
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $89,974
Award facts
- Contract value 100% obligated
- $89,973.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Portland, OR 97239, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$34,715 | |
| Supplemental Agreement for work within scope | -$106,876 | |
| Original award | $231,566 |
About this award
This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $89,973.91, is a Blanket Purchase Agreement (BPA) call order for the drug Tyvaso (treprostinil) 0.6 mg/mL solution refill kits.
The contract is placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, and does not utilize any set-aside designations. The contract supports the VA's mission of providing specialized medical treatments to veterans, with the performance period extending from October 1, 2016 to September 30, 2017. United Therapeutics holds two significant Indefinite Delivery Vehicles (IDVs) with the VA, including this $50 million BPA and a $198 million FSS contract, which facilitate the procurement of their pharmaceutical product portfolio to VA medical facilities nationwide.
Quick answers
Who was awarded contract VA26017J1606?
VA26017J1606 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2016.
How much is contract VA26017J1606 worth?
The government has obligated $89,974 on VA26017J1606.
Is contract VA26017J1606 an order under another contract?
Yes. VA26017J1606 is a BPA call under V797D40275-VA797P15A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26017J1606 competed?
The extent of competition for VA26017J1606 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award